baber/WOPTO huggingface dataset:
Patent NZ-225767-A (NZ)
Title: Growth hormone (gh) fragments suited to raising antibodies which potentiate the activity of the hormone in a vertebrate
Inventor: RILEY JOHN HAMILTON
IPC: C07K19/00
Filed: 1988-08-10
Abstract: A peptide having primary structural homology to a continuous sequesnce of amino acid residues of bovine growth hormone in the region spanning positions 1 to 18, or positions 55 to 72, or positions 97-110 or positions 122-138 thereof or antigenically equivalent peptides thereto or salts thereof. The peptide is preferably selected from the following peptides:     (a) 122-138   (b) 119-131   (c) 130-143   (d) 123-137   (e) 133-146 wherein each may be bovine, ovine, porcine, avian or salmon, or salts of any of these. The peptide may be administered to vertebrates in antigenic formulations in order to enhance growth or (in mammals) lactation.
Patent NZ-226671-A (NZ)
Title: Indole derivatives having substituent group containing imidazole, pyrrole and optionally xanthenyl groupings; pharmaceutical compositions
Inventor: ROBERTSON ALAN DUNCAN
IPC: C07D405/14
Filed: 1988-10-21
Abstract: The present invention is concerned with compounds of formula (I) <CHEM>  wherein R, R<1> and R<2> are independently selected from hydrogen and C1-4 alkyl; R<3> and R<4> are independently selected from hydrogen, C1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C1-4 alkyl and aryl), provided R<3> NOTEQUAL benzyl or substituted benzyl when R<4> = H;  m is an integer of from 0 to 2;  n is an integer of from 0 to 3;  (W) is a group of formula (i), (ii), (iii), or (iv) <CHEM> wherein Y is selected from oxygen, methylene and @N-R<5>, where R<5> is hydrogen, C1-4 alkyl, or benzyl, Z and Z min  are independently selected from @C=O, @C-S and methylene, and the chiral centre * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions;  X is a group selected from    aryl (including heteroaryl)  xanthenyl  dibenzofuranyl   which group is optionally substituted by an atom or group selected from    C1-6 alkyl (including cycloalkyl)  aryl (including heteroaryl)  C1-4 alkoxy  aryloxy  alkylsulphonyl  arylsulphonyl  halogen  cyano  carbamoyl  alkylcarbamoyl  dialkylcarbamoyl  arylcarbamoyl  diarylcarbamoyl  carbamoylmethyl  N-alkylcarbamoylmethyl  N,N-dialkylcarbamoylmethyl  N-arylcarbamoylmethyl  N,N-diarylcarbamoylmethyl  alkoylamino  aroylamino  alkoylaminomethyl  aroylaminomethyl  alkylsulphamino  arylsulphamino  alkylsulphaminomethyl  arylsulphaminomethyl  sulphamyl  alkylsulphamyl  dialkylsulphamyl  arylsulphamyl  diarysulphamyl   the aryl group(s) of aryl-containing substituents being optionally substituted by halogen or C1-4 alkoxy; and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.
Patent NZ-228731-A (NZ)
Title: Food or drink containing fructosyl oligosaccharides in which the carbohydrate units are joined via beta bonds
Inventor: BITON JACQUES
IPC: A23L33/20
Filed: 1989-04-13
Abstract: The invention relates to a method intended for reducing the total daily energy intake in man or animals, wherein one or more fructosyle oligosaccharides containing from 3 to 8 glycoside units linked via beta bonds replace all or part of the energy-rich sugars in products intended for feeding or for dietetic purposes. 
<??>The invention also relates to nutritional or dietetic products or beverages, wherein the energy-rich sugars which they contain are wholly or partially replaced by such fructosyle oligosaccharides.
Patent NZ-247867-A (NZ)
Title: Oxazolidine derivatives and their preparation
Inventor: BOURZAT JEAN-DOMINIQUE
IPC: C07D263/04
Filed: 1991-11-22
Abstract: Prodn. of taxane derivs. of formula (I) comprises (a) condensing oxazolidine deriv. (II) with taxane (III) to form cpd. (IV); (b) treating this with acid (under conditions which do not affect R1' and R2) to give cpd. (V); (c) reacting (V) to introduce an N-acyl gp., forming (VI); (d) removing protecting gps. to give (I) which is opt. isolated and purified. In formulae, R = tert. butoxy or phenyl; R1 = H or acetyl; Ar = aryl; Boc = tert. butoxycarbonyl; R6 and R7 = 1-4C alkyl (opt. substd. by aryl) or aryl, or together complete a 4-7 membered ring; R1' = acetyl or OH protecting gp.; R2 = OH-protecting gp.
Patent NZ-259092-A (NZ)
Title: Determining a predisposition to hypertension by comparison of molecular variants of the angiotensinogen (agt) gene
Inventor: LALOUEL JEAN-MARC
IPC: C12Q1/68
Filed: 1993-09-29
Abstract: The association of the molecular variant G-6A of the angiotensinogen gene with human hypertension is disclosed. The determination of this association enables the screening of persons to identify those who have a predisposition to high blood pressure.
Patent NZ-280929-A (NZ)
Title: Long nip paper machine press belt: made by spirally winding strip and coating with polymeric resin
Inventor: GRONDAHL ERIK WILHELM
IPC: D06M101/34
Filed: 1996-02-02
Abstract: A belt (16) for use on a long nip press (10) for dewatering a fibrous web (24) includes a base (40) assembled by spirally winding a prepared structure strip (34) in a plurality of non-overlapping turns. Successive turns are abutted against and joined to those previously wound by sewing or otherwise bonding along the continuous spiral seam 38 thus formed. The prepared structure strip (34) may be a fabric strip (34) of a single- or multi-layer weave, woven from lengthwise (48) and crosswise yarns (50), which may be monofilament yarns of a synthetic polymeric resin. At least one side of the base (40), the side which will be on the inside of the belt and which slides over the pressure shoe (14) is coated with a polymeric resin, such as polyurethane, to protect it from wear and render it impervious to oil and water. The coating (54) is ground and buffed to provide the belt (16) with a smooth surface and a uniform thickness. <IMAGE>
Patent NZ-313774-A (NZ)
Title: The h-y antigen
Inventor: GOULMY ELS A J M
IPC: C12N5/0783
Filed: 1996-07-29
Abstract: H-Y is a transplantation antigen that can lead to rejection of HLA-matched male organ and bone marrow grafts by female recipients, and may play a role in pregnancy and spermatogenesis.  However, the origin and function of H-Y antigens has eluded researchers for 40 years.  Shown is that one human H-Y peptide antigen presented by HLA-B7 is an 11 residue peptide derived from SMCY, an evolutionarily conserved Y chromosomal protein. A homologous gene on the X chromosome, SMCX, differs by two residues in the same region. Also show n is a peptide antigen recognized by two HLA-A2.1 restricted T cell clones, which is also encoded by SMCY.  The identification of H-Y offers prospects for improvements in transplantation outcome, prenatal diagnosis and fertilization strategies.
Patent NZ-322938-A (NZ)
Title: Method of detecting telomerase activity
Inventor: EMRICH THOMAS
IPC: C12Q1/68
Filed: 1996-11-27
Abstract: The invention concerns a method for the detection of telomerase activity wherein(a) a sample to be tested is provided,(b) a first primer suitable as a telomerase substrate and nucleoside triphosphates are added and the reaction mixture is incubated under conditions under which a primer extension by the telomerase can take place,(c) an amplification of the extension product produced by the telomerase is carried out,(d) the amplification product produced in step (c) is immobilized on a solid phase and(e) the immobilized amplification product is detected qualitatively or/and quantitatively. Furthermore the invention concerns a suitable reagent kit for carrying out the method.
Patent NZ-331107-A (NZ)
Title: Radiation and melt treated ultra high molecular weight polyethylene prosthetic devices
Inventor: MERRILL EDWARD W
IPC: A61F2/32
Filed: 1997-02-11
Abstract: A medical prosthesis for use within the body which is formed of radiation treated ultra high molecular weight polyethylene (UHMWPE) having substantially no detectable free radicals, is described. Preferred prostheses exhibit reduced production of particles from the prosthesis during wear of the prosthesis, and are substantially oxidation resistant. Methods of manufacture of such devices and material used therein are also provided. A medical prosthesis in the form of a hip-joint prosthesis is generally illustrated at 10 described in figure shown above. The prosthesis shown has a conventional ball head 14 connected by a neck portion to a stem 15. The ball head can be of conventional design and formed of stainless steel or other alloys as known in the art. The radius of the ball head closely conforms to the inner cup radius of an acetabular cup 12 that can be mounted in cement 13 directly to the pelvis 11.
Patent NZ-332464-A (NZ)
Title: use of a combination of interleukin-10 and a steroid to treat inflammation
Inventor: SMITH SIDNEY R
IPC: A61P29/00
Filed: 1997-04-29
Abstract: A combination of IL-10 and a steroid is used in the manufacture of medicament for treating or preventing septic shock or an autoimmune disease in mammal. The steroid can be prednisone, dexamethasone, fluticasone or betamethasone.
Patent NZ-332895-A (NZ)
Title: Insulin sensitivity enhancers for preventing hyperuricemia
Inventor: IWASAKI KOICHI
IPC: A61K31/4439
Filed: 1998-11-19
Abstract: The insulin sensitivity enhancers, such as troglitazone, have the ability to treat and/or prevent hyperuricemia. They may be used for treating diseases such as gout, urinary calculus, hyperuricemic nephropathy and Lesch-Nyhan syndrome. Preferred insulin sensitivity enhancers are: i)5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]thiazolidine-2,4-dione, ii)5-[4-(6-acetoxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]thiazolidine-2,4-dione, iii)5-[4-(6-ethoxycarbonyloxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]-thiazolidine-2,4-dione, iv) 5-{4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl}thiazolidine-2,4-dione, v) 5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dione, vi) 5-{4-[2-(N-methyl-N-pyrid-2-ylamino)ethoxy]benzyl}thiazolidine-2,4-dione, vii)5-(4-{2-[1-(4-pyrid-2'-ylphenyl)ethylideneaminooxy]ethoxy}benzyl) thiazolidine-2,4-dione,    viii) 4-{4-[2-(2-phenyl-5-methyl-4-oxazolyl)ethoxy]benzyl}-3,5-isoxazolidinedione, ix) 5-{4-(5-methoxy-3-methylimidazo[4,5-b]pyridin-2-ylmethoxy)benzyl} thiazolidine-2,4-dione, x) 5-[4-(1-methylindolin-2-ylmethoxy)benzyl]thiazolidine-2,4-dione, xi) 5-[4-(1-methylbenzimidazol-2-ylmethoxy)benzyl]thiazolidine-2,4-dione, xii) 5-[4-(6-methoxy-1-methylbenzimidazol-2-ylmethoxy)benzyl]thiazolidine-2,4-dione, xiii) 5-[4-(5-hydroxy-1,4,6,7-tetramethylbenzimidazol-2-ylmethoxy)benzyl]-thiazolidine-2,4-dione, xiv) 5-{4-[3-(5-methyl-2-phenyloxazol-4-yl)propionyl]benzyl}thiazolidine-2,4-dione, or xv) 5-[6-(2-fluorobenzyloxy)-2-naphthylmethyl]thiazolidine-2,4-dione; or a pharmaceutically acceptable salt thereof.
Patent NZ-336512-A (NZ)
Title: Image based document processing system comparing recognition results from primary and secondary lists
Inventor: WU HUI
IPC: G06V30/10
Filed: 1999-06-29
Abstract: The method of processing documents in an image-based document processing system to associate recognition results from a primary source results list with corresponding results from a secondary source results list comprises:  a)	scanning a first type of document to obtain scanned data; b)	scanning a second type of document to obtain scanned data; c)	processing scanned data from the first type of document to provide recognition results associated with the first type of document; d)	processing scanned data from the second type of document to provide recognition results associated with the second document; e)	storing recognition results associated with the first type of document in a primary list; f)	storing recognition results associated with the second type of document in a secondary list; g)	comparing recognition results from the primary list with recognition results from the secondary list to determine if an exact match occurs and thereby associate a first set of recognition results from the primary list and a first set of results from the secondary list and h)	comparing recognition results from the primary list with recognition results from the secondary list to determine if an approximate match occurs, when an exact match fails to occur in step (g), and thereby associate a second set of recognition results from the primary list and a second set of results from the secondary list.  An apparatus for use in the method of processing documents as defined above is also disclosed.
Patent NZ-510384-A (NZ)
Title: Sustained release ranolazine formulations
Inventor: WOLFF ANDREW A
IPC: A61K31/495
Filed: 1999-09-09
Abstract: A sustained release ranolazine formulation contains a mixture of at least 50 wt% ranolazine and a pH-dependent binder to form a film that is mostly insoluble in aqueous media below pH 4.5 and soluble in aqueous media above pH 4.5.  The pH-dependent binder inhibits the release of ranolazine from the sustained release dosage form when the sustained release dosage form is subjected to an aqueous environment having a pH of the stomach and that promotes the release of a therapeutic amount of ranolazine in an aqueous solution having ph above 4.5.
Patent NZ-515252-A (NZ)
Title: Carboxylic acid derivatives that inhibit the bindng of integrins to their receptors
Inventor: BIEDIGER RONALD J
IPC: C07D413/04
Filed: 2001-11-02
Abstract: Described are compounds that may be used in the inhibition of the binding of Alpha4Beta1 integrin to its receptors and the use of these compounds in the manufacture of medicaments. Addition to 515248
Patent NZ-516346-A (NZ)
Title: A device for evaluating traffic on a computer network to detect traffic abnormalities such as a denial of service attack
Inventor: BRENDEL JEURGEN
IPC: H04L12/26
Filed: 2001-12-21
Abstract: A traffic evaluation device includes a data interface to receive one or both network traffic and data indicative of the characteristics of network traffic and processing means operable to evaluate the network traffic and/or data received by the data interface for predetermined characteristics that indicate that the network traffic contains a subset of abnormal traffic and upon detection of the predetermined characteristics retrieve from memory information defining a superset and provide an output defining the superset. The superset is a portion of the network traffic that contains the subset and defines network traffic that may be redirected and/or clocked by a network device. An apparatus for monitoring network traffic for a traffic profile abnormality includes data volume observing means for observing the volume of data communicated to or within a network and data classification means for classifying data communicated to or within the network into one or more of a plurality of classes and a processing means to operable to: a) for at least one pair of classes compute a ratio of observed data volume of one class or a function of the observed data volume of one or more classes to observed data volume of another class or function of observed data volume of one or more classes; b) evaluate whether the one or more ratios indicate abnormal network traffic against predetermined criteria and if so output either or both of a signal indicating the potential occurrence of an abnormality or instructions to a network device to take predetermined action in response to the abnormality.
Patent NZ-517904-A (NZ)
Title: Initiation of oestrus in early postpartum mammals by the adminstration of prostaglandin followed by progesterone
Inventor: LAMMING G E
IPC: A61P15/08
Filed: 2000-09-06
Abstract: A method of initiating oestrus or increasing milk production in a female mammal, preferably a diary cow, comprises supplying a prostaglandin or prostaglandin analogue early post partum and subsequently treating with a progesterone or progesterone equivalent. The prostaglandin analogue is preferably cloprostenol, dinoprost, tiaprost, luprostiol or etiproston tromethamine and the progesterone equivalent is preferably flugestone acteate, medroxyprogesteron acetate, altrenogest or norgestamet.
Patent NZ-530722-A (NZ)
Title: Use of atazanavir to reduce plasma LDL and/or triclyceride levels in an HIV-infected patient
Inventor: BECHTOLD CLIFFORD M
IPC: A61K31/496
Filed: 2002-08-21
Abstract: Disclosed is the use of atazanavir in the manufacture of a medicament for use in place of a HIV protease inhibitor to reduce elevated plasma LDL and/or triglyceride levels in an HIV-infected patient resulting from therapy with one or more HIV protease inhibitors.
Patent NZ-530985-A (NZ)
Title: Bv8 nucleic acids and polypeptides with mitogenic activity
Inventor: FERRARA NAPOLEONE
IPC: C12N5/02
Filed: 2002-08-27
Abstract: Bv8 or a nucleic acid molecule encoding Bv8 can be used in the preparation of a medicament for inducing proliferation of endothelial cells, enhancing survival of endothelial cells, for treating steroidogenic tissue disorder, such as lipoid congenital adrenal hyperplasia, infertility, sexual maturation, androgen-dependent tumors, precocious puberty, McCune-Albright syndrome, adrenal-hypoplasia congenital and hypogonadotropic hypogonadism. A Bv8 antagonist, such as an antibody can be used in the manufacture of medicament for inhibiting proliferation and survival of endothelial cells, or angiogenesis, for treating cancer.
Patent NZ-532304-A (NZ)
Title: Fence straining apparatus
Inventor: NEWDICK WAYNE
IPC: E04H17/02
Filed: 2004-04-14
Abstract: A method of straining net fencing (and apparatus adapted to that purpose) where there is an operator engaging behind a spreader strand of a plurality of members depending from an elongate member of the apparatus which is positioned from the operator's side. Thereafter, straining the fence occurs. The application of a rotational affect whereby the elongate member and the members engage the spreader strand(s) ensures sufficient deformation of the engaged web run strands to prevent any sliding tendency of the spreader strand(s).
Patent NZ-535891-A (NZ)
Title: Apparatus for controlling the drying of previously baked goods
Inventor: ZHANG HUA
IPC: A47J39/00
Filed: 2004-10-12
Abstract: A merchandiser for displaying and warming previously baked dough products, such as a filled pastry shell or other baked dough product, under controlled drying conditions, including an enclosure having one or more wall members that define an interior space, with at least a portion of one of the wall members being transparent, an opening for access into the interior space, a removable support member within the enclosure that includes at least one support surface for previously baked dough products and a spacing arrangement configured and adapted to reproducibly position the support member within the interior space of the enclosure member to facilitate substantially uniform airflow around each support surface and throughout the enclosure, and a heating system for providing heated air in the enclosure, wherein the substantially uniform airflow provides controlled drying of the previously baked dough products in the enclosure. A merchandiser including an air-moving device, a heat source, and a reflective device disposed therebetween is also included.
Patent NZ-536263-A (NZ)
Title: Tire inflation system apparatus and method
Inventor: WHITE JAY
IPC: B60C23/00
Filed: 2004-03-05
Abstract: A method of inflating a tyre without causing over-inflation is disclosed. An air source (12) is connected to the tyre (14) by a pneumatic conduit (16), with a tyre pressure retention valve (18, 24) being located in the conduit. During a step-up procedure the inflation pressure of the tyre is determined, with small bursts of air being communicated from the air source to a portion of the conduit between the source and pressure retention valve. The tyre is inflated in an extended-pulse procedure, with extended bursts of air being communicated to the tyre from the air source until a predetermined target pressure is reached.
Patent NZ-537933-A (NZ)
Title: System and method for piggybacking data across an open data channel of a wireless device during idle time
Inventor: SPRIGG STEPHEN A
IPC: H04L12/56
Filed: 2003-08-19
Abstract: A system, method, and program for transmitting data across an idle open communication channel from a wireless device. The wireless device includes a computer platform and a plurality of device resources that selectively utilize a open communication channel to communicate with other devices across the network, and each device resource selectively requests notification of an idle open communication channel, and all device resources that have requested such notification are notified upon an idle open communication channel occurring, and each notified device resource can selectively transmit data across the open communication channel prior to the closure thereof.
Patent NZ-539334-A (NZ)
Title: Multivalent metal salts of organoboronic acids for treating thrombosis
Inventor: MADGE DAVID JONATHAN
IPC: C07K5/065
Filed: 2003-09-09
Abstract: Salts of a pharmaceutically acceptable multivalent metal and an organoboronic acid drug are disclosed. Examples of such metals are calcium, magnesium and zinc. The organoboronic acid drug may be a boropeptide protease inhibitor. The salts may be formulated in oral dosage form. These salts are used in the manufacture of oral medicaments for treating thrombosis.
Patent NZ-540156-A (NZ)
Title: Stable recombinant poxvirus harbouring at least two expression cassettes that are not naturally part of the poxviral genome, such as the cowpox virus A-type inclusion (ATI) promoters
Inventor: LEYRER SONJA
IPC: C12N15/863
Filed: 2003-11-12
Abstract: Described are recombinant poxviruses comprising in the viral genome at least two expression cassettes, each comprising the cowpox ATI promoter or a derivative thereof and a coding sequence, wherein the expression of the coding sequence is regulated by said promoter. The virus is useful as a vaccine or as part of a pharmaceutical composition.
Patent NZ-540642-A (NZ)
Title: Compounds and compositions for use as foaming or frothing agents in ore and coal flotation
Inventor: LEEMING PHILIP JOSEPH
IPC: C07C43/11
Filed: 2003-12-09
Abstract: Disclosed is a composition comprising at least two compounds of formula (II), wherein R1 and R2 are each independently C1-C4 alkyl, and n is an integer e" 0 and wherein the average molar value of n for the total of the compounds of formula (II) in said composition is in the range of 1 to 2. Also disclosed is a method of preparing said composition, said method comprising reacting an excess of C3-C9 secondary alcohol with ethylene oxide in the presence of a catalyst in an ethoxylation vessel to form a mixture of two or more compounds of formula (II), separating at least a portion of unreacted secondary alcohol from the mixture and recycling the unreacted secondary alcohol back to the ethoxylation vessel
Patent NZ-541516-A (NZ)
Title: Compositions comprising fatty acids and amino acids
Inventor: TROUP JOHN P
IPC: A23L1/305
Filed: 2004-02-23
Abstract: Disclosed are combinations which comprise at least one cis-polyunsaturated fatty acid, at least one amino acid and optionally at least one diabetes medicine for simultaneous, separate or sequential use in the prevention, delay of progression or treatment of diseases, especially metabolic disorders and in particular type 2 diabetes and diseases and conditions associated with diabetes.